Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Genetown crawled date : 2021 - 10 - 20 save search
Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer
Published: 2021-10-20 (Crawled : 21:00) - biospace.com/
RDUS | $17.64 -2.86% -2.83% 280K
|
Health Technology
|
| O: 36.48%
H: 9.0%
C: -14.74%
positive results cancer topline elacestrant phase 3 breast cancer trial elascestrant
Kymera to Hold Webcast and Conference Call Discussing Data from its KT-474 Phase 1 Trial to Be Presented at the 4th Annual Targeted Protein Degradation Summit on October 27th
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
KYMR | $35.71 3.96% 3.78% 440K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -4.19%
phase 1 trial conference
Stealth BioTherapeutics Receives Refusal to File Letter from the FDA
Published: 2021-10-20 (Crawled : 20:00) - biospace.com/
MITO | $0.32 0.25%
|
Health Technology
|
| O: -13.04%
H: 8.33%
C: 5.0%
fda iot
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.